Literature DB >> 2937754

Lymphocytoplasmapheresis in multiple sclerosis: one-year results in 6 patients.

A Ghezzi, G A Zaffaroni, D Caputo, R Guaschino, D Alesso, P Gasco, R Montanini, C L Cazzullo.   

Abstract

6 patients with definite MS underwent lymphocytoplasmapheresis for one year. Clinical data, evoked potential recordings and peripheral blood lymphocyte helper/suppressor ratio were assessed before and after the treatment and were compared with those of a control group of 10 multiple sclerosis patients. Lymphocytoplasmapheresis did not significantly modify clinical and laboratory findings compared with the control group.

Entities:  

Mesh：

Year:  1986        PMID： 2937754     DOI： 10.1007/bf02230429

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN： 0392-0461


  13 in total

1.  FURTHER NOTES ON DISABILITY EVALUATION IN MULTIPLE SCLEROSIS, WITH SCALE MODIFICATIONS.

Authors:  J F KURTZKE
Journal:  Neurology       Date:  1965-07       Impact factor: 9.910

2.  Lymphocytapheresis in chronic progressive multiple sclerosis: results of a preliminary trial.

Authors:  J Rose; H Klein; J Greenstein; D McFarlin; L Gerber; H McFarland
Journal:  Ann Neurol       Date:  1983-11       Impact factor: 10.422

3.  An assessment of plasma exchange in progressive multiple sclerosis.

Authors:  H L Weiner
Journal:  Neurology       Date:  1985-03       Impact factor: 9.910

4.  Lymphocytapheresis in chronic progressive multiple sclerosis: immunologic and clinical effects.

Authors:  S L Hauser; M Fosburg; S V Kevy; H L Weiner
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

5.  New diagnostic criteria for multiple sclerosis: guidelines for research protocols.

Authors:  C M Poser; D W Paty; L Scheinberg; W I McDonald; F A Davis; G C Ebers; K P Johnson; W A Sibley; D H Silberberg; W W Tourtellotte
Journal:  Ann Neurol       Date:  1983-03       Impact factor: 10.422

6.  Plasmapheresis decreases neuroelectric blocking activity in multiple sclerosis.

Authors:  D Stefoski; C L Schauf; B C McLeod; C P Haywood; F A Davis
Journal:  Neurology       Date:  1982-08       Impact factor: 9.910

7.  Monoclonal antibody analysis of blood T-cell subsets in multiple sclerosis.

Authors:  M Zaffaroni; D Caputo; A Ghezzi; S Marforio; C L Cazzullo
Journal:  Ital J Neurol Sci       Date:  1984-03

8.  Plasma exchange (PE) and lymphocytapheresis (LCA) in multiple sclerosis (MS).

Authors:  P Höcker; V Stellamor; K Summer; M Mann
Journal:  Int J Artif Organs       Date:  1984-01       Impact factor: 1.595

9.  Lymphocytoplasmapheresis in multiple sclerosis: preliminary laboratory findings.

Authors:  A Ghezzi; M Zaffaroni; D Caputo; R Guaschino; P Gasco; R Montanini; C L Cazzullo
Journal:  Ital J Neurol Sci       Date:  1985-03

Review 10.  Multiple sclerosis: evidence for immunopathogenesis.

Authors:  R P Lisak
Journal:  Neurology       Date:  1980-07       Impact factor: 9.910
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.